Biohacker Bryan Johnson, the entrepreneur known for spending millions of dollars on longevity research, has revealed that he has been diagnosed with autoimmune gastritis (AIG), a chronic condition in which the body’s immune system mistakenly attacks the stomach lining. The announcement marks a significant shift in Johnson’s health journey, as he says he is now exploring artificial intelligence-designed therapies that could one day “reset” malfunctioning immune cells.
Johnson, whose Project Blueprint has focused on slowing aging and extending human lifespan, argues that existing treatments only manage the disease rather than address its underlying cause. While his proposed AI-driven approach remains experimental, his diagnosis has brought renewed attention to autoimmune gastritis, a condition that often goes undetected until complications emerge.
What is autoimmune gastritis?
Autoimmune gastritis is a chronic autoimmune disease in which the immune system mistakenly attacks parietal cells, the specialized cells that produce stomach acid and intrinsic factor.
Intrinsic factor is essential for absorbing vitamin B12, making the condition more than just a digestive disorder. Over time, damage to the stomach lining can interfere with nutrient absorption and increase the risk of long-term complications.
Unlike common gastritis caused by infections, medications, or alcohol use, autoimmune gastritis develops because the body’s immune system targets its own healthy tissue.
Why is Bryan Johnson’s diagnosis attracting attention?
Johnson has become one of the world’s most recognizable longevity advocates.
After selling Braintree to PayPal in 2013 for approximately $800 million, he began investing heavily in Project Blueprint, a rigorous health program involving extensive medical testing, dietary interventions, exercise, and experimental therapies aimed at slowing biological aging.
His latest diagnosis is notable because it highlights the limits of preventive health, even for someone who undergoes frequent medical monitoring.
Johnson announced the diagnosis on X, writing that “my stomach is eating itself,” while adding that autoimmune gastritis affects an estimated 2% to 5% of people worldwide and often remains undiagnosed.
What symptoms does autoimmune gastritis cause?
One of the biggest challenges with autoimmune gastritis is that symptoms are often vague or develop gradually.
Early signs may include:
- Persistent bloating.
- Abdominal discomfort.
- Heartburn.
- Fatigue.
- Loss of appetite.
- Nausea.
Because these symptoms overlap with many common digestive disorders, diagnosis is frequently delayed.
As the disease progresses, patients may develop:
- Iron deficiency.
- Vitamin B12 deficiency.
- Pernicious anemia.
- Neurological symptoms caused by vitamin deficiencies.
- Increased long-term risk of stomach cancer.
A diagram illustrating how autoimmune gastritis damages stomach cells and reduces vitamin B12 absorption would help readers understand the disease process.
How was Bryan Johnson diagnosed?
Johnson said his diagnosis came after extensive medical evaluation.
Although a recent colonoscopy showed no abnormalities, doctors performed a bidirectional endoscopy to examine his digestive tract more closely.
Biopsies collected from three areas of his stomach reportedly revealed:
- Early autoimmune gastritis.
- Atrophy limited to acid-producing regions of the stomach.
- No widespread damage to the remaining stomach tissue.
Johnson also noted that he has lived with hypothyroidism since age 21 and has long experienced persistently low ferritin levels despite otherwise normal blood counts, findings that may have pointed toward an underlying autoimmune process.
Why does Bryan Johnson believe AI could help?
Rather than relying solely on existing treatments, Johnson says he hopes artificial intelligence can eventually help develop targeted antibodies capable of eliminating the immune cells responsible for attacking his stomach.
His idea centers on designing highly specific therapies that could selectively remove malfunctioning immune cells while preserving healthy immune function.
At present, this concept remains investigational.
Although AI is already accelerating drug discovery by identifying promising molecules and predicting how proteins interact, AI-designed antibody therapies for autoimmune gastritis have not been approved for routine clinical use.
Johnson has acknowledged that his proposed approach is based on emerging scientific research rather than established medical treatment.
What treatments are currently available?
There is currently no cure for autoimmune gastritis.
Instead, treatment focuses on preventing complications and correcting nutritional deficiencies.
Standard management typically includes:
- Vitamin B12 supplementation.
- Iron replacement when needed.
- Monitoring for anemia.
- Regular endoscopic surveillance in higher-risk patients.
- Management of associated autoimmune conditions.
Doctors may also recommend periodic screening because long-term inflammation can increase the likelihood of certain stomach cancers.
Johnson says his lifestyle contributed to the disease
In discussing his diagnosis, Johnson reflected on earlier stages of his life.
He said his childhood diet consisted largely of sugary cereals, soda, and fast food, followed by years of chronic stress while raising three children and building a business.
According to Johnson, those years were accompanied by significant weight gain and prolonged depression.
While lifestyle choices can influence overall health, scientists generally consider autoimmune diseases to result from a combination of genetic susceptibility and environmental factors rather than any single cause.
Researchers continue to study how infections, nutrition, gut microbiota, and other triggers contribute to autoimmune disorders.
How is AI changing autoimmune disease research?
Johnson’s announcement comes as artificial intelligence is becoming increasingly important in biomedical research.
AI systems are helping researchers:
- Identify potential drug candidates faster.
- Analyze massive genomic datasets.
- Predict protein structures.
- Design therapeutic antibodies.
- Personalize treatment strategies.
Several pharmaceutical companies are already using AI during early-stage drug discovery.
However, most AI-generated therapies must still undergo years of laboratory research and clinical trials before reaching patients.
A timeline showing the drug development process, from AI discovery through clinical trials and FDA approval, would provide useful context.
Why this matters beyond Bryan Johnson
Johnson’s diagnosis has drawn attention because of his public profile, but autoimmune gastritis affects many people who have never heard of the condition.
Its subtle symptoms often delay diagnosis until nutritional deficiencies or anemia become severe.
His experience also highlights a broader trend in medicine: the growing intersection between artificial intelligence and personalized healthcare.
While AI may eventually transform treatment for autoimmune diseases, experts caution that today’s patients should continue following evidence-based medical care while emerging therapies undergo scientific evaluation.
The bottom line
Bryan Johnson’s autoimmune gastritis diagnosis adds a new dimension to his high-profile quest to extend human health and lifespan.
His plan to explore AI-designed therapies reflects the rapid pace of innovation in biotechnology, but it remains an experimental concept rather than an established treatment.
For now, autoimmune gastritis continues to be managed through early diagnosis, nutritional support, and careful medical monitoring. Johnson’s case may help raise awareness of a disease that often develops quietly but can have serious long-term consequences if left untreated.
TL;DR
- Bryan Johnson says he has been diagnosed with autoimmune gastritis (AIG).
- The disease causes the immune system to attack the stomach’s acid-producing cells.
- Johnson plans to explore AI-designed antibodies as a possible future treatment.
- His proposed approach is experimental and not part of current standard medical care.
- Autoimmune gastritis can lead to vitamin deficiencies, anemia, and an increased risk of stomach cancer if left untreated.